Feed MEDS
ME

DataMEDS AI, Inc.

MEDS · NASDAQ

$3.76 -36.91% (-$2.20)
1M +189.23%
Market Cap $12.2M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9
Valuation
90 /100
Cheap
P/S 1.52x
P/E N/A
EV/FFO N/A
Growth
-
N/A
EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
0 /100
Weak
Gross margin 125.11%
FCF margin 169.34%
Net margin 1,100.30%
Quality
4 /100
Poor
ROIC 439.90%
Asset turnover 0.24x
ROA 269.47%
Debt
0 /100
High
Current ratio 0.14x
Int. coverage -33.01x
Debt/Equity N/A
Stability
50 /100
Moderate
Beta -1.52x
Rev. volatility N/A
Profitable years N/A

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about MEDS
Online

About the company

TRxADE HEALTH, Inc. (MEDS) is an American company operating in the healthcare technology sector, focusing on the development and operation of a platform for electronic trading of pharmaceuticals and healthcare products. This platform connects pharmacies, distributors, and drug manufacturers, enabling efficient and transparent purchasing and selling of healthcare products. TRxADE HEALTH aims to improve the distribution and availability of medications and provide tools to simplify business operations within the healthcare industry. Investors interested in technological innovations in healthcare and enhancements in the distribution chain might see potential in TRxADE HEALTH, Inc. (MEDS) shares for growth in this sector.

Sector

Healthcare

Industry

Medical - Distribution

CEO

Prashant Patel

Employees

31

Headquarters

Tampa

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.